查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球輸尿管支架市場
市場調查報告書
商品編碼
1143394

2022-2029 年全球輸尿管支架市場

Global Ureteral Stents Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計輸尿管支架市場在預測期間（2022-2029 年）將以 5.8% 的複合年增長率增長。

輸尿管支架是細而柔韌的管子，可通過因各種疾病而阻塞的輸尿管恢復尿液流動。市場上用於支架病例管理和患者安全的創新界面平台對患者和醫生都有好處。流行病學數據顯示，腎結石病患病率不斷上升，進一步增加了對輸尿管支架的需求。

市場動態

全球輸尿管支架市場受到泌尿系統疾病發病率上升、腎功能損害老年人口增加和腎移植增加的推動。

腎移植數量的增加和人口老齡化正在推動全球市場的增長。

預計腎移植的增加將推動市場。例如，根據全球捐贈和移植觀察站的數據，2020 年捐贈了超過 80,926 個腎臟，2021 年捐贈了大約 98,349 個。個人首次接受腎移植的中位等待時間約為 3.6 年，具體取決於適用性、健康狀況和器官可用性。根據與 NHS England 合作的 NHS Blood and Transplant 發布的一份報告，截至 2022 年 2 月 24 日，共有 4,658 個有效的候補名單，其中 98 人是兒童。這個數字預計會增長。因此，腎移植的增加和對泌尿系統功能障礙的日益關注導致對提高術後便利性的輸尿管支架的需求激增。

此外，預計不斷增長的老年人口將推動全球輸尿管支架市場。例如，根據世界衛生組織的數據，65 歲的人口將從 2020 年估計的 10 億增加到 2030 年的 14 億，到 2050 年世界老年人口將翻一番（21 億）。到 2050 年， 80歲及以上人口將達到4.26億，其中大部分增長在發展中國家。老年病學的增加也反映在腎結石等醫療問題的增加上。老年科醫生和腎臟科醫生在這些患者的護理中發揮著重要作用，需要協調的多學科護理。

支架移除後並發症的高風險阻礙了全球市場的增長。

然而，支架移除後並發症的高風險可能會抑制市場。使用尿道支架可能會發生與脫位、阻塞和感染有關的幾種並發症。人們還可能感到尿急、排尿頻率增加、腎痛和尿液混濁。這些因素將刺激醫學研發部門開發更好的輸尿管支架替代品，並可能在預測期內影響市場增長。

行業分析

《全球輸尿管支架市場報告》根據波特五力、創新、新產品發布和定價等各種行業因素對市場進行了深入分析。

細分分析

預計多環支架細分市場將在預測期內（2022-2029 年）主導全球市場。

由於與泌尿系統疾病患病率上升、老年人口增加和並發症減少相關的多環支架段的技術進步，多環支架段將在預測期內（2022-2029 年）增長。預計將在率最高。此外，這些支架的高采用率以及主要供應商採用各種營銷策略正在推動其增長。多環輸尿管支架由訓練有素的醫生設計，用於暫時促進尿液從腎臟排入膀胱。多環輸尿管支架的市場領導者是 MEDpro Medical，它在單端多環雙 J 支架和雙端多環雙 J 支架方面取得了成功。此外，Surgimedik 的膽道雙 J 支架（均為 endo-multi-loop）是獨一無二的。

區域分析

估計北美將主導全球輸尿管支架市場。

北美將在 2021 年主導全球輸尿管支架市場，慢性腎髒病發病率上升，腎結石等泌尿系統疾病，老年人口不斷增加，久坐不動的生活方式增加，腎移植預測期（2022-2029 年）由於 .例如，根據 LifeSource 的統計，截至 2022 年 7 月 20 日，超過 89,898 名美國公民正在等待挽救生命的腎臟移植手術。此外，根據 Kidney.org 的數據，每年有超過 500,000 人因一個問題而去急診室。此外，總部位於美國的主要公司採取了各種策略，如產品發布、公司擴張和合併，以推動北美市場的增長。例如，大學醫院克利夫蘭醫學中心正在臨床試驗中開發 RELIEF(TM) 輸尿管支架，以評估逆行尿流和遠端螺旋膀胱位置。這是一種一次性輸尿管支架裝置，在其傳統功能的基礎上進行了新的設計改進，可讓尿液從腎臟進入膀胱，最大限度地減少尿液反流和防止膀胱刺激，還具有減輕症狀和改善患者護理的好處。該考試的完成日期為 2022 年 12 月。

競爭格局

在全球輸尿管支架市場運營的主要公司有波士頓科學公司、B. Braun Holding GmbH & Co.KG、庫克集團公司、康樂保公司、C. R. Bard, Inc.、Medline Industries, Inc.、Allium Medical Solutions Ltd、Penn Medical A/S、Teleflex Incorporated 和 Olympus Corporation。主要參與者採取了各種策略，如產品發布、併購、合作夥伴和聯盟，為全球輸尿管支架市場的增長做出貢獻。例如，2022 年 5 月 2 日，Cook Medical 的 Winston-Salem 製造工廠獲得了 ISO 14001 認證。同樣在 2021 年 5 月 28 日，奧林巴斯公司收購了以色列醫療器械公司 Meditate。

波士頓科學公司

概述

波士頓科學公司專注於介入放射學、介入心髒病學、外周介入、神經調節、神經血管介入、電生理學、心臟外科、血管外科、內窺鏡檢查，是一家全球領先的生物醫學和生物技術工程公司，從事製造用於醫療器械的醫療器械腫瘤科、泌尿科、婦科等介入醫學專科。波士頓科學公司成立於 1979 年，總部位於美國馬薩諸塞州馬爾堡。

產品組合

Boston Scientific 的輸尿管支架產品組合如下。

Contour 輸尿管支架、Contour Injection 輸尿管支架組、Percuflex 泌尿分流支架組、Percuflex 輸尿管支架、Polaris Loop 輸尿管支架。

Polaris Ultra 輸尿管支架、Retromax Plus 內窺鏡支架、Stretch VL Flexima 輸尿管支架組、Tria 輸尿管支架等。

全球輸尿管支架市場報告將提供對 40 多個 市場數據表、超過 45 個數字和 200 頁（大約）的訪問。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 腎移植數量增加
      • 老年人口增加
    • 約束因素
      • 支架取出後的並發症
    • 商機
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 多循環
  • 開口支架
  • 閉合端支架
  • 雙尾纖支架

第 8 章按材料分類

  • 金屬支架
  • 矽膠支架
  • 混合支架
  • 聚氨酯支架
  • 其他

第 9 章按應用程序

  • 腎結石
  • 腎移植
  • 腫瘤
  • 尿失禁
  • 其他

第 10 章，最終用戶

  • 醫院和診所
  • 門診手術中心
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 13 章公司簡介

  • 波士頓科學公司
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • B. Braun Holding GmbH & Co. KG
  • Cook Group Incorporated
  • Coloplast Ltd.
  • C. R. Bard, Inc.
  • Medline Industries, Inc
  • Allium Medical Solutions Ltd
  • Penn Medical A/S
  • Teleflex Incorporated
  • Olympus Corporation

第14章 DataM

簡介目錄
Product Code: DMMD1957

Market Overview

Ureteral Stents Market is expected to grow at a CAGR of 5.8% during the forecasting period (2022-2029).

Ureteral stents are thin, flexible tubes that restore urine flow through blocked ureters due to various disorders. Innovative interface platforms available in the market for stent case management and patient safety are useful for both patients and physicians. Epidemiological data revealed that the prevalence of kidney stone disease is increasing, which further increases the demand for ureteral stents.

Market Dynamics

The global ureteral stents market is driven by the rising incidence of urological diseases, the rising geriatric population with kidney disorders, and an increasing number of kidney transplants.

The rising number of kidney transplants and the growing geriatric population fuel the growth of the global market.

The increasing number of kidney transplants is expected to drive the market. For instance, according to the Global Observatory on Donation and Transplantation, in 2020, there were over 80,926 kidneys donated, and in 2021 around 98,349 kidneys were donated. The median wait time for an individual's first kidney transplant is around 3.6 years and varies depending on compatibility, health, and availability of organs. According to the report published by NHS Blood and Transplant, which works in collaboration with NHS England, the active waiting list as of 24 February 2022 has 4,658 patients waiting for a kidney, including 98 children. This number is expected to rise. Thus, the growing number of renal transplants and raising concerns related to urological dysfunction have surged the demand for ureteral stents for post-operative convenience.

Furthermore, the growing geriatric population is expected to drive the global ureteral stents market. For instance, as per World Health Organization, the number of people aged 65 is expected to rise from an estimated 1 billion in 2020 to 1.4 billion in 2030; the world's geriatric population will double (2.1 billion) by 2050 and between 2020 and 2050, the persons aged 80 years or older will reach to 426 million, with most of the increase in developing countries. This increase in geriatrics will be reflected by the rise in medical problems such as kidney stones. It requires coordinated care by multiple specialties, with geriatricians and nephrologists playing a vital role in treating these patients.

The high risk of complications post-stent removal will hamper the global market growth.

However, the high risk of complications after the removal of stents is likely to restrain the market. Some complications related to dislocation, blockage, and infection may arise because of the usage of a urinary stent. The patient may also feel an increased urgency or frequency of urination, kidney pain, and blood in the urine. These factors surge the medical research and development departments to develop a better alternative to ureteral stents and can affect the market growth in the forecast period.

Industry Analysis

The global ureteral stents market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.

Segment Analysis

The multiloop stents segment is predicted to dominate the global market during the forecast period (2022-2029).

The multiloop stents segment is expected to grow at the highest rate during the forecast period (2022-2029) because of the rise in the prevalence of urological disorders, the growing geriatric population, and technological advancements in the multiloop stents segment associated with reduced complications. Also, the high adoption of these stents and the adoption of various marketing strategies by critical vendors foster its growth. The Multiloop Ureteral Stent is intended to temporarily facilitate urine drainage from kidney to bladder by a trained physician. One of the market leaders on the multiloop ureteral stents front is MEDpro Medical, with their successful Double J Stent one-end multiple loops and Double J Stent, both end multiple loop products. Also, the Biliary double J stent, both end multiple loops of Surgimedik, is one of a kind.

Geographical Analysis

North America is estimated to command the global ureteral stents market.

North America dominated the global ureteral stents market in 2021 and is estimated to hold a significant market size over the forecast period (2022-2029) owing to the rising incidences of urological diseases like chronic kidney diseases, kidney stones, Etc., rising geriatric population base, increasing sedentary lifestyles, growing kidney transplantations. For instance, according to LifeSource statistics, as of July 20, 2022, over 89,898 United States citizens are waiting for a lifesaving kidney transplant. Furthermore, as per Kidney.org, more than half a million people yearly go to emergency rooms stones one problem. In addition, the US-based major players are adopting various strategies, including product launches, company expansion, mergers, and others, fueling the market's growth in North America. For instance, University Hospitals Cleveland Medical Center is developing the RELIEF™ Ureteral Stent in clinical trials to assess Retrograde Urinary Reflux and Distal Coil Bladder Position. It is a single-use, disposable ureteral stent device which provides the traditional function of allowing the passage of urine from the kidney to the bladder with new design enhancements, also with the benefits of minimizing urinary reflux and decreasing irritative bladder symptoms to improve patient care. According to the reports, the estimated study completion date is December 2022.

Competitive Landscape

The major players operating in the global ureteral stents market are Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, Coloplast Ltd., C. R. Bard, Inc., Medline Industries, Inc., Allium Medical Solutions Ltd, Penn Medical A/S, Teleflex Incorporated, and Olympus Corporation. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the ureteral stents market globally. For instance, on 02 May 2022, Cook Medical's Winston-Salem manufacturing facility secured ISO 14001 Certification. Also, on May 28, 2021, Olympus Corporation acquired Medi-Tate, an Israeli Medical Device Company.

Boston Scientific Corporation

Overview:

Boston Scientific Corporation is a leading biomedical/biotechnology engineering Company involved in the global production of medical devices that are used in interventional medical specialties, such as interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific was founded in 1979 and is headquartered in Marlborough, Massachusetts, U.S.

Product Portfolio:

Boston Scientific Corporation's product portfolio for ureteral stents has

Contour Ureteral Stents, Contour Injection Ureteral Stent Set, Percuflex Urinary Diversion Stent Set, Percuflex Ureteral Stent, Polaris Loop Ureteral Stent,

Polaris Ultra Ureteral Stent, Retromax Plus Endopyelotomy Stent, Stretch VL Flexima Ureteral Stent Set, Tria Ureteral Stents, Etc.

The global ureteral stents market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Number of Kidney Transplants
      • 4.1.1.2. The Growing Geriatric Population
    • 4.1.2. Restraints
      • 4.1.2.1. Post Stent Removal Complications
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Multiloop
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Open-end stents
  • 7.4. Closed-end stents
  • 7.5. Double pigtail stents

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 8.1.2. Market Attractiveness Index, By Material Segment
  • 8.2. Metal Stents
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Silicone Stents
  • 8.4. Hybrid Stents
  • 8.5. Polyurethane Stents
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Kidney Stones
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Kidney Transplantation
  • 9.4. Tumors
  • 9.5. Urinary Incontinence
  • 9.6. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals and Clinics
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Boston Scientific Corporation
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. B. Braun Holding GmbH & Co. KG
  • 13.3. Cook Group Incorporated
  • 13.4. Coloplast Ltd.
  • 13.5. C. R. Bard, Inc.
  • 13.6. Medline Industries, Inc
  • 13.7. Allium Medical Solutions Ltd
  • 13.8. Penn Medical A/S
  • 13.9. Teleflex Incorporated
  • 13.10. Olympus Corporation

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us